EVZIO(R) NALOXONE HCl
- Product NDC
- 51662-1495
- 11-digit product format
- 516621495
- Labeler code
- 51662
- Product ID
- 51662-1495_9f4536f0-d9de-3b36-e053-2a95a90ab8f1
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- EVZIO(R) NALOXONE HCl
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAMUSCULAR; SUBCUTANEOUS
- Labeler
- HF Acquisition Co LLC, DBA HealthFirst
- Application
- NDA209862
- Marketing category
- NDA
- Marketing start
- 2020-01-11
- Marketing end
- 0000-00-00
- Substance
- NALOXONE HYDROCHLORIDE
- Active strength
- 2 mg/.4mL
- Pharmacologic classes
- Opioid Antagonist [EPC],Opioid Antagonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 51662-1495-1 | EVZIO(R) NALOXONE HCl | 0.4 mL in 1 DOSE PACK | INJECTION, SOLUTION | 0.4 | | 2 |
| 51662-1495-1 | EVZIO(R) NALOXONE HCl | 2 in 1 CARTON | INJECTION, SOLUTION | 2 | | 2 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 51662-1495 | EVZIO(R) NALOXONE HCL INJECTION, SOLUTION [HF ACQUISITION CO LLC, DBA HEALTHFIRST] | 2 | Legacy NDC, 2 package rows | 20200224_9be31bdf-e220-2978-e053-2a95a90a03c6.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 51662-1495-1 | 51662149501 | 2 DOSE PACK in 1 CARTON (51662-1495-1) > .4 mL in 1 DOSE PACK | 2 dose pack | 2020-01-11 | 0000-00-00 | No | No | Current |